Related Experiment Videos

Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein

X H Liang1, L K Kleeman, H H Jiang

  • 1Departments of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

Journal of Virology
|October 10, 1998
PubMed

Insights

The anti-apoptotic gene Bcl-2 protects against lethal encephalitis by reducing Sindbis virus replication. A novel protein, Beclin, interacts with Bcl-2 and enhances host defense against viral infection.

Area of Science:

  • Neurovirology
  • Molecular Biology
  • Immunology

Background:

  • The anti-apoptotic gene bcl-2 confers protection against lethal Sindbis virus encephalitis in mice.
  • Understanding the molecular mechanisms of Bcl-2-mediated protection is crucial for developing antiviral strategies.

Purpose of the Study:

  • To identify Bcl-2-interacting proteins in the central nervous system involved in Sindbis virus infection.
  • To elucidate the role of the identified protein, Beclin, in Sindbis virus pathogenesis and antiviral defense.

Main Methods:

  • Yeast two-hybrid screening of an adult mouse brain library to identify Bcl-2 interacting partners.
  • Confirmation of Bcl-2 and Beclin interaction using fluorescence resonance energy transfer (FRET) microscopy.
  • Construction and infection of mice with recombinant Sindbis viruses expressing different forms of Beclin.

Main Results:

  • A novel 60-kDa coiled-coil protein, Beclin, was identified as a Bcl-2 interacting partner.
  • Mice infected with Sindbis virus expressing full-length Beclin (SIN/beclin) showed significantly higher survival rates (71%) compared to controls.
  • SIN/beclin infected brains exhibited reduced viral RNA, apoptosis, and viral titers, indicating Beclin's role in antiviral defense.

Conclusions:

  • Beclin is a novel Bcl-2-interacting protein with a potential role in antiviral host defense.
  • Beclin expression enhances protection against Sindbis virus infection in the central nervous system.
  • Targeting Beclin-Bcl-2 interactions may offer therapeutic avenues for viral encephalitis.

Related Concept Videos